Insider trading · Q3 2026 · CIK 856982

Merit Medical Systems Inc (MMSI) insider trading.

In Q3 2026, insiders at Merit Medical Systems Inc reported 4 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $2.5M.

Transactions
4
Purchases (P)
0
Sales (S)
2
Net shares, P minus S
-28,949
Insiders
3
Last filed
2026-09-09

Insiders

InsiderRelationshipTransactionsBuysSales
Peterson Neil W.Officer · CHIEF OPERATING OFFICER202
Lewis SheriOfficer · EVP of Global Operations100
Voigt Michel J.Officer · CHIEF HUMAN RESOURCES OFFICER100

Transactions

4 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-04Lewis SheriA (A)8,371$08,371Form 4
2026-08-24Voigt Michel J.G (D)650$045,412Form 4
2026-08-24Peterson Neil W.S (D)7,500$90.4518,051Form 4
2026-08-04Peterson Neil W.S (D)21,449$8525,551Form 4

Transaction codes in this quarter

Get MMSI insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=856982&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · MMSI company page · Merit Medical Systems Inc on SEC.gov

Questions

Are insiders buying or selling Merit Medical Systems Inc (MMSI)?

In Q3 2026, insiders at Merit Medical Systems Inc reported 4 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $2.5M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Merit Medical Systems Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/mmsi.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.